[go: up one dir, main page]

NO20003529D0 - Treatment of dyskinesia - Google Patents

Treatment of dyskinesia

Info

Publication number
NO20003529D0
NO20003529D0 NO20003529A NO20003529A NO20003529D0 NO 20003529 D0 NO20003529 D0 NO 20003529D0 NO 20003529 A NO20003529 A NO 20003529A NO 20003529 A NO20003529 A NO 20003529A NO 20003529 D0 NO20003529 D0 NO 20003529D0
Authority
NO
Norway
Prior art keywords
dyskinesia
treatment
Prior art date
Application number
NO20003529A
Other languages
Norwegian (no)
Other versions
NO20003529L (en
Inventor
Eldad Melamed
Ruth Djaldetti
Ilan Ziv
Original Assignee
Mor Research Applic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12288398A external-priority patent/IL122883A0/en
Priority claimed from IL12710298A external-priority patent/IL127102A0/en
Application filed by Mor Research Applic Ltd filed Critical Mor Research Applic Ltd
Publication of NO20003529D0 publication Critical patent/NO20003529D0/en
Publication of NO20003529L publication Critical patent/NO20003529L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20003529A 1998-01-09 2000-07-07 Treatment of dyskinesia conditions NO20003529L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12288398A IL122883A0 (en) 1998-01-09 1998-01-09 Pharmaceutical compositions for the treatment of dyskinesias
IL12710298A IL127102A0 (en) 1998-11-17 1998-11-17 Pharmaceutical compositions for the treatment of dyskinesias
PCT/IL1999/000003 WO1999034785A2 (en) 1998-01-09 1999-01-05 Treatment of dyskinesias

Publications (2)

Publication Number Publication Date
NO20003529D0 true NO20003529D0 (en) 2000-07-07
NO20003529L NO20003529L (en) 2000-09-08

Family

ID=26323572

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003529A NO20003529L (en) 1998-01-09 2000-07-07 Treatment of dyskinesia conditions

Country Status (10)

Country Link
EP (1) EP1043996A2 (en)
JP (1) JP2002500181A (en)
KR (1) KR20010033978A (en)
CN (1) CN1290166A (en)
AU (1) AU1780699A (en)
BR (1) BR9906821A (en)
CA (1) CA2317811A1 (en)
NO (1) NO20003529L (en)
PL (1) PL342098A1 (en)
WO (1) WO1999034785A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3295900A (en) * 1999-03-12 2000-10-04 Aventis Pharma S.A. Amyotropic lateral sclerosis treatment with a combination of riluzole and an ampa receptor antagonist
FR2790670A1 (en) * 1999-03-12 2000-09-15 Aventis Pharma Sa Treatment or prevention of amyotrophic lateral sclerosis, using synergistic combination of riluzole and AMPA receptor antagonist, e.g. 5H,10H-imidazo (1,2-a) indeno (1,2-e) pyrazin-4-one derivative
US6297254B1 (en) 1999-12-01 2001-10-02 Aventis Pharma S. A. Method for the prevention or treatment of a motoneuron disease
FR2801793B1 (en) * 1999-12-01 2003-07-04 Aventis Pharma Sa COMBINATION OF ERGOLIN AND RILUZOLE AND ITS USE AS A MEDICINAL PRODUCT
FR2809620B1 (en) * 2000-06-05 2002-08-02 Aventis Pharma Sa USE OF RILUZOLE OR ITS SALTS FOR THE PREVENTION AND TREATMENT OF ADRENOLEUCODYSTROPHY
EP1256340B1 (en) * 2001-05-08 2003-08-13 Schwarz Pharma Ag Improved transdermal therapeutic system for the treatment of Parkinson's disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2688138B1 (en) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa APPLICATION OF AMINO-2 TRIFLUOROMETHOXY-6 BENZOTHIAZOLE TO OBTAIN A MEDICINE FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS.
FR2700117B1 (en) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application of anti-convulsants in the treatment of Parkinson's disease and parkinsonian syndromes.

Also Published As

Publication number Publication date
BR9906821A (en) 2000-10-17
NO20003529L (en) 2000-09-08
JP2002500181A (en) 2002-01-08
CA2317811A1 (en) 1999-07-15
WO1999034785A3 (en) 1999-09-16
EP1043996A2 (en) 2000-10-18
WO1999034785A2 (en) 1999-07-15
AU1780699A (en) 1999-07-26
CN1290166A (en) 2001-04-04
PL342098A1 (en) 2001-05-21
KR20010033978A (en) 2001-04-25

Similar Documents

Publication Publication Date Title
ID27092A (en) MAKING OF ANHYDRIDAL FTALATES
FI980732A0 (en) Foerfarande Foer koppling av dataoeverfoeringsstroemmar
FI980343A0 (en) Foerfarande Foer kontrollering av effekt
FI980783A0 (en) Foerfarande Foer utformning av en signaleringsfoerbindelse
FI980465A0 (en) Foerfarande Foer installering av tjaenster
NO994790D0 (en) Estimation of permeability
FI980327A0 (en) Foerfarande Foer foermedling av telefonsamtal
FI980150A0 (en) Foerfarande Foer oeverfoering av bildinformation
FI980735A0 (en) Foerfarande Foer hantering av foerdroejning
ID28032A (en) TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2
NO20003529D0 (en) Treatment of dyskinesia
FI980044A0 (en) Foerfarande Foer behandling av en fiberbana
NO20014845D0 (en) Use of arylalkanoylpyridazines
FI980519A0 (en) Foerfarande Foer behandling av massa
NO20014477L (en) Treatment of osteoarthritis
PT1232141E (en) ETERIES OF O-DESMETIL-VENLAFAXIN
NO20005062D0 (en) Treatment of panic attacks
FI980095A0 (en) Foerfarande Foer byggande av fartyg
NO20000274D0 (en) Treatment of fluids
FI980710A0 (en) Foerfarande Foer smaeltning av stenmaterial Foer mineralullsproduktion
FI980839A0 (en) Framstaellning av lactakt
FI980443A0 (en) Anordning Foer maetning av en roerlig pappers- eller kartonbanas egenskaper
ID29414A (en) TREATMENT OF DEPRESSION
FI980146A0 (en) Foerfarande Foer roentgenavbildning av huvud- och halsomraodet
NO996166L (en) Procedures for the treatment of odluor

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application